Leonard Kruimer
Président chez BIOINVENT INTERNATIONAL AB
Fortune : 2 M $ au 31/05/2024
Profil
Leonard Kruimer currently works at BioInvent International AB, as Chairman from 2018, Pharming Group NV, as Independent Non-Executive Director, Basilea Pharmaceutica AG, as Independent Director from 2022, Zealand Pharma A, as Independent Director from 2019, Advent International BV, as Director, Global Investments Netherlands Pcc Ltd., as Director, and AI Global Investments (Netherlands) PCC Ltd., as Director from 2020.
Mr. Kruimer also formerly worked at Profibrix BV, as Chairman-Supervisory Board from 2011 to 2013, Oncolytics Biotech, Inc., as Independent Director from 2019 to 2022, T.I.P.
Europe Ltd., as Managing Director from 1993 to 1995, PepsiCo, Inc., as Principal, Crucell NV, as Chief Financial Officer from 1997 to 2011, Royal Boskalis Westminster NV, as Principal, Pricewaterhouse & Co., as Auditor from 1980 to 1982, Janssen Vaccines & Prevention BV, as Chief Financial Officer, to-BBB Holding BV, as Chief Financial Officer, to-BBB technologies BV, as Chief Financial Officer from 2014 to 2015, Kwik-Fit Europe BV, as Principal, Continental Can Europe, as Principal, and SkylineDx BV, as Chief Financial Officer from 2015 to 2016.
Mr. Kruimer received his undergraduate degree from the University of Massachusetts and Masters Business Admin degree from Harvard Business School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ZEALAND PHARMA A/S
0,02% | 31/12/2023 | 15 300 ( 0,02% ) | 1 M $ | 31/05/2024 |
| 17/07/2023 | 33 538 ( 0,05% ) | 117 829 $ | 31/05/2024 | |
PHARMING GROUP NV
0,02% | 29/05/2024 | 104 257 ( 0,02% ) | 92 865 $ | 31/05/2024 |
Postes actifs de Leonard Kruimer
| Sociétés | Poste | Début |
|---|---|---|
| BIOINVENT INTERNATIONAL AB | Président | 24/04/2018 |
| ZEALAND PHARMA A/S | Directeur/Membre du Conseil | 04/04/2019 |
| PHARMING GROUP N.V. | Directeur/Membre du Conseil | 19/05/2021 |
| BASILEA PHARMACEUTICA AG | Directeur/Membre du Conseil | 01/01/2022 |
Advent International BV
 Advent International BV Investment ManagersFinance Part of Advent International LP, Advent International BV is a private equity firm. The company is based in Amsterdam, Netherlands. | Directeur/Membre du Conseil | - |
| Global Investments Netherlands Pcc Ltd. | Directeur/Membre du Conseil | - |
AI Global Investments (Netherlands) PCC Limited
 AI Global Investments (Netherlands) PCC Limited Financial ConglomeratesFinance AI Global Investments (Netherlands) PCC Ltd. functions as an investment holding Dutch company. The private company is based in Amsterdam, the Netherlands. | Directeur/Membre du Conseil | 01/04/2020 |
Anciens postes connus de Leonard Kruimer
| Sociétés | Poste | Fin |
|---|---|---|
| ONCOLYTICS BIOTECH INC. | Directeur/Membre du Conseil | 16/06/2022 |
SkylineDx BV
 SkylineDx BV Medical/Nursing ServicesHealth Services SkylineDx BV develops molecular diagnostic tests for blood cancers. The firm focuses on the development and commercialization of gene signature-based diagnostic tests, which assist healthcare professionals in making personalized treatment decisions for individual patients. Its products include MMprofiler and AMLprofiler. The company was founded by Dharminder S. Chahal and Bob Löwenberg in 2005 and is headquartered in Rotterdam, the Netherlands. | Directeur Financier/CFO | 01/01/2016 |
| ░░░░░░ ░░░░░░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Leonard Kruimer
| Harvard Business School | Masters Business Admin |
| University of Massachusetts | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 6 |
|---|---|
| PEPSICO, INC. | Consumer Non-Durables |
| BIOINVENT INTERNATIONAL AB | Health Technology |
| ZEALAND PHARMA A/S | Health Technology |
| ONCOLYTICS BIOTECH INC. | Health Technology |
| PHARMING GROUP N.V. | Health Technology |
| BASILEA PHARMACEUTICA AG | Health Technology |
| Entreprise privées | 14 |
|---|---|
Crucell NV
 Crucell NV Pharmaceuticals: MajorHealth Technology Crucell NV develops, produces and markets vaccines, proteins and antibodies that prevent and treat infectious diseases. It focuses in the research & development of innovative immunization candidates to fight against tuberculosis, malaria, HIV/AIDS, influenza, rabies, polio and several other diseases which are the global health problems. The firms prod8ucts include Quinvaxem, Epaxal, Hepavax-Gene, Vivotif and Dukoral against paediatric, respiratory and travel or endemic infections. The company was founded by Domenico Valerio on October 9, 2000 and is headquartered in Leiden, Netherlands. | Health Technology |
Janssen Vaccines & Prevention BV
 Janssen Vaccines & Prevention BV Pharmaceuticals: MajorHealth Technology Janssen Vaccines & Prevention BV manufactures and supplies biopharmaceutical products. The company was founded in 2000 and is headquartered in Leiden, the Netherlands. | Health Technology |
ProFibrix BV
 ProFibrix BV BiotechnologyHealth Technology ProFibrix BV develops and markets products for the hemostasis and regenerative medicine markets. Its product in pipeline, ProFibrix, is a hemostatic agent for mild to moderate surgical bleeding. The firm operates through its offices located in Leiden and Seattle. It is a subsidiary of The Medicines Company. The company was founded in 2004 by Jaap Koopman and is headquartered in Leiden, the Netherlands. | Health Technology |
Royal Boskalis Westminster NV
 Royal Boskalis Westminster NV Engineering & ConstructionIndustrial Services Royal Boskalis Westminster NV engages in the provision of maritime services. It operates through the following segments: Dredging and Inland Infra, Offshore Energy, and Salvage, Towage, and Holding. The Dredging and Inland Infra segment is involved in all activities required to remove silt, sand, and other layers from the seabed and river bed and in some cases in coastal protection and land reclamation. The Offshore Energy segment focuses on offshore contracting capabilities and services of the group in international energy sector, including oil and gas companies and providers of renewable energy, such as wind power. Salvage, Towage, and Holding segment provides assistance to incoming and outgoing ocean-going vessels through the joint ventures of the group, Keppel Smith, Saam Smit Towage, and Kotug Smit Towage. The company was founded in 1910 and is headquartered in Papendrecht, the Netherlands. | Industrial Services |
Kwik-Fit Europe BV
 Kwik-Fit Europe BV Other Consumer ServicesConsumer Services Kwik-Fit Europe BV provides automotive parts repair including tyres, brakes, exhausts, and car servicing. It operates as a subsidiary of Kwik-Fit Group Ltd. The company was founded in 1999 and is located in Harderwijk, the Netherlands. | Consumer Services |
| Continental Can Europe | |
to-BBB technologies BV
 to-BBB technologies BV Pharmaceuticals: MajorHealth Technology BBB Therapeutics BV develops medicines for brain disease treatment. The firm uses its platform technology to enhance the delivery of established and marketed drugs over the blood brain-barrier. It offers its patented central nervous system (CNS) drug targeting technology to their partners in pharmaceutical and biotechnology industry. The firm's products include 2B3-101 and 2B3-201. The company was founded by Pieter Jaap Gaillard, Bert de Boer, and Alfred N. Nijkerk in 2003 and is headquartered in Leiden, the Netherlands. | Health Technology |
T.I.P. Europe Ltd.
 T.I.P. Europe Ltd. Other TransportationTransportation T.I.P. Europe Ltd. engaged in the operation of warehousing and storage facilities for land transport activities. The company was founded on March 26, 1986 and was headquartered in London, the United Kingdom. | Transportation |
to-BBB Holding BV
 to-BBB Holding BV Pharmaceuticals: GenericHealth Technology to-BBB Holding BV operated as a holding company with interest in providing central nervous system drug technology to the pharmaceutical and biotechnology industries. The firm developed medicines for the treatment of brain diseases. The company was headquartered in The Hague, the Netherlands. | Health Technology |
SkylineDx BV
SkylineDx BV Medical/Nursing ServicesHealth Services SkylineDx BV develops molecular diagnostic tests for blood cancers. The firm focuses on the development and commercialization of gene signature-based diagnostic tests, which assist healthcare professionals in making personalized treatment decisions for individual patients. Its products include MMprofiler and AMLprofiler. The company was founded by Dharminder S. Chahal and Bob Löwenberg in 2005 and is headquartered in Rotterdam, the Netherlands. | Health Services |
| Global Investments Netherlands Pcc Ltd. | |
Advent International BV
Advent International BV Investment ManagersFinance Part of Advent International LP, Advent International BV is a private equity firm. The company is based in Amsterdam, Netherlands. | Finance |
| Pricewaterhouse & Co. | Commercial Services |
AI Global Investments (Netherlands) PCC Limited
AI Global Investments (Netherlands) PCC Limited Financial ConglomeratesFinance AI Global Investments (Netherlands) PCC Ltd. functions as an investment holding Dutch company. The private company is based in Amsterdam, the Netherlands. | Finance |
